🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Status
Completed
Location
University of Alberta
Start Date
2014-10
Trial ID
NCT02774239
Treatments Being Tested
All patients will receive the investigational medicinal product BP-SCIG 20%...
Status
Recruiting
Location
Municipal Non-Profit Enterprise "Cherkasy Regional Children's Hospital" of the Cherkasy Regional Council
Start Date
2025-12-17
Trial ID
NCT07346859
Treatments Being Tested
The objective of this study is to assess the efficacy, safety, tolerability...
Status
Completed
Location
Study site
Start Date
2010-09
Trial ID
NCT01199705
Treatments Being Tested
The purpose of this study is to determine whether Hizentra is a safe and ef...
Status
Completed
Location
Phoenix Neurological Associates
Start Date
2015-05
Trial ID
NCT02100969
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study site
Start Date
2007-09
Trial ID
NCT00542997
Treatments Being Tested
This study is a continuation of the study ZLB06\_001CR with the objective o...
Status
Completed
Location
Study Site
Start Date
2008-08
Trial ID
NCT00751621
Treatments Being Tested
Chimeric antigen receptor (CAR) T cells are special immune cells taken from...
Status
Recruiting
Location
University of Alberta
Start Date
2025-06-01
Trial ID
NCT06989541
Treatments Being Tested
The objective of this study is to assess the long-term safety, tolerability...
Status
Completed
Location
Study site
Start Date
2011-04
Trial ID
NCT01458171
Treatments Being Tested
The purpose of the study is to determine whether biweekly (every 2 weeks) a...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2020-11-24
Trial ID
NCT04566692
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study Site
Start Date
2006-11
Trial ID
NCT00419341
Treatments Being Tested